Non-alcoholic fatty liver disease and cardiovascular risk

被引:76
|
作者
Brea, Angel [1 ]
Puzo, Jose [2 ]
机构
[1] Hosp San Pedro, Unidad Lipidos, Serv Med Interna, Logrono, Spain
[2] Hosp San Jorge, Unidad Lipidos, Bioquim Clin, Huesca, Spain
关键词
Fatty liver; Cardiovascular disease; Alcohol; Non-alcoholic fatty liver disease; GAMMA-GLUTAMYL-TRANSFERASE; CORONARY-HEART-DISEASE; TRIGLYCERIDE TRANSFER PROTEIN; ENDOPLASMIC-RETICULUM STRESS; RANDOMIZED CONTROLLED-TRIAL; TERM-FOLLOW-UP; HEPATIC STEATOSIS; METABOLIC SYNDROME; INSULIN-RESISTANCE; WEIGHT-LOSS;
D O I
10.1016/j.ijcard.2012.09.085
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The term "Non-alcoholic fatty liver disease" (NAFLD) covers a series of liver lesions similar to those induced by alcohol, but not caused by alcohol use. The importance of NAFLD lies in the high prevalence in Western societies and, from the point of view of the liver, in its progression from steatosis to cirrhosis and liver cancer. More recently, NAFLD has been found to be associated with lipid metabolism disorders, the deposition of fat outside of the adipocytes, insulin resistance and Metabolic Syndrome. Also attributed to NAFLD is a heightened systemic pro-inflammatory state, which accelerates arteriosclerosis, thereby increasing cardiovascular risk and associated cardiovascular events. Here we provide an update to the etiopathogenesis of NAFLD, its influence on cardiovascular disease, and the treatment options. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1109 / 1117
页数:9
相关论文
共 50 条
  • [1] Non-alcoholic fatty liver disease and cardiovascular risk
    Brea Hernando, Angel
    Puzo Foncillas, Jose
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2010, 22 (06): : 259 - 271
  • [2] NON-ALCOHOLIC FATTY LIVER DISEASE AND CARDIOVASCULAR RISK
    Pisetta, C.
    Pelizzari, G.
    Pigozzi, M. G.
    Salvetti, M.
    Paini, A.
    Muiesan, M. L.
    De Ciuceis, C.
    Ricci, C.
    Rizzoni, D.
    JOURNAL OF HYPERTENSION, 2019, 37 : E304 - E304
  • [3] Non-alcoholic fatty liver disease and risk of cardiovascular disease
    Lonardo, Amedeo
    Sookoian, Silvia
    Pirola, Carlos J.
    Targher, Giovanni
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (08): : 1136 - 1150
  • [4] Non-alcoholic Fatty Liver Disease and Cardiovascular Disease Risk
    Targher G.
    Current Cardiovascular Risk Reports, 2010, 4 (1) : 32 - 39
  • [5] Non-alcoholic fatty liver disease and cardiovascular risk: an update
    Mullish, Benjamin H.
    Forlano, Roberta
    Manousou, Pinelopi
    Mikhailidis, Dimitri P.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 12 (12) : 1175 - 1177
  • [6] Cardiovascular Risk Factors in Non-Alcoholic Fatty Liver Disease
    Hagstrom, Hannes
    Nasr, Patrik
    Ekstedt, Mattias
    Hammar, Ulf
    Stal, Per
    Hultcrantz, Rolf W.
    Kechagias, Stergios
    HEPATOLOGY, 2018, 68 : 950A - 950A
  • [7] Cardiovascular risk factors in non-alcoholic fatty liver disease
    Hagstrom, Hannes
    Nasr, Patrik
    Ekstedt, Mattias
    Hammar, Ulf
    Stal, Per
    Askling, Johan
    Hultcrantz, Rolf
    Kechagias, Stergios
    LIVER INTERNATIONAL, 2019, 39 (01) : 197 - 204
  • [8] Non-alcoholic fatty liver disease and increased risk of cardiovascular disease
    Targher, Giovanni
    Arcaro, Guido
    ATHEROSCLEROSIS, 2007, 191 (02) : 235 - 240
  • [9] Non-alcoholic fatty liver disease and cardiovascular disease
    Santos, Raul D.
    Agewall, Stefan
    ATHEROSCLEROSIS, 2012, 224 (02) : 324 - 325
  • [10] Management of Cardiovascular Risk in the Non-alcoholic Fatty Liver Disease Setting
    Linero, Paula Luque
    Castilla-Guerra, Luis
    EUROPEAN CARDIOLOGY REVIEW, 2024, 19